0001358403-16-000238.txt : 20160729
0001358403-16-000238.hdr.sgml : 20160729
20160729174814
ACCESSION NUMBER: 0001358403-16-000238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160727
FILED AS OF DATE: 20160729
DATE AS OF CHANGE: 20160729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spencer David M.
CENTRAL INDEX KEY: 0001627362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 161795266
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
4
1
wf-form4_146982888122668.xml
FORM 4
X0306
4
2016-07-27
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001627362
Spencer David M.
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Chief Scientific Officer
Common Stock
2016-07-27
4
S
0
10000
15
D
176082
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 21, 2016 by the Reporting Person.
Includes 1,523 shares acquired under the Issuer's Employee Stock Purchase Plan on June 10, 2016.
/s/ David M. Spencer
2016-07-29